Positive ARIEL-3 readout

The PARP space continues to generate positive data. Clovis Oncology just released positive rucaparib topline data in the maintenance treatment … More

Celyad news and White Paper

Belgian cell therapy pioneer Celyad has just announced that their natural killer cell program dubbed THINK (THerapeutic Immunotherapy with NKR-2) … More

Positive Lynparza readout

AstraZeneca has just announced positive Breast cancer results from a head to head Phase III trial which compares its PARP … More

Stemline reports setback

Stemline on Thursday had to report that another patient died from capillary lead syndrome (CLS) after receiving SL-401, the company’s … More

TCR making progress

Adaptimmune just presented a poster at the society for Immunotherapy of Cancer annual meeting 2016 where they provide some encouraging … More